CHPA welcomes congressional focus on OMUFA reauthorization
“OMUFA has been instrumental in ensuring timely FDA review of OTC medicines, driving innovation, and enhancing consumer safety,” said CHPA President and CEO Scott Melville.
Pharmacy
AAM issues statement on FDA job cuts
“Today's staff reductions may undermine the Agency’s ability to approve and ensure the safety of lower-cost generic and biosimilar medicines.”
CVS Health commits $100,000 to Congressional Medal of Honor Society's HonorCare program
New program helps nation's heroes maintain and improve their health after sacrificing so much.
Cardinal Health completes acquisition of the Advanced Diabetes Supply Group
ADSG accelerates growth strategy for Cardinal Health at-Home Solutions.
Massive layoffs at health agencies begin
The widespread layoffs and restructuring efforts have raised concerns about these agencies' future capacity to respond to public health crises, regulate critical medical products, and conduct essential research.
Pennsylvania Employees Benefit Trust Fund selects Aetna for medical benefits
Additionally, the Aetna medical plans will be offered to approximately 11,000 non-Medicare eligible Commonwealth retiree members and their dependents enrolled in the Retired Employees Health Program (REHP).
Drug companies expanding U.S. manufacturing amid tariff pressures
GlobalData’s Emerging Market Outsourcing report reveals that this push for domestic production could lead to increased production costs and inflationary pressures on drug prices.
Walgreens Specialty Pharmacy earns accreditations from URAC and ACHC
URAC is a leading independent healthcare accrediting body, and ACHC is a globally recognized accrediting organization.
Rite Aid shares tips for allergy season
Group VP Summer Kerley looks at the ABC's of the allergy season and the best remedies.
Walgreens agrees to settle allegations of overbilling Medicaid programs
The settlement resolves, in part, claims brought by a whistleblower under the qui tam provisions of the federal, Massachusetts, and Georgia False Claims Acts.
Armas Pharmaceuticals announces the reintroduction of Lidocaine Jelly 2% 30mL to the U.S. market
Lidocaine Jelly 2% is a topical anesthetic used in various medical applications, including urological and endoscopic procedures, to provide localized pain relief.
McKesson Canada expands patient access to cutting-edge Radioligand Therapy in Ontario
Radioligand therapy represents a breakthrough in nuclear medicine,
Shoppers Drug Mart opens first of seven pharmacy care clinics in Surrey, British Columbia
New clinics will increase access to health care in Canada’s fastest growing city.
Walgreens to shutter 500 stores in 2025
With approximately 8,500 stores currently operating across the country, Walgreens' planned closures will see nearly one in seven locations shuttered by 2027.
Journavx for moderate to severe acute pain now available at retail pharmacies
Journavx fills a critical gap between over-the-counter pain medicines (e.g., aspirin and ibuprofen), which offer only modest relief, and opioids, which are effective but come with serious side effects.
LillyDirect platform expands to improve access to Alzheimer's care
Eli Lilly and Company enhances digital healthcare offerings to address delays in diagnosis and treatment.